Health Care [ 11/12 ] | Biotechnology [ 53/76 ]
NASDAQ | Common Stock
Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects.
It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.
The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology.
Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 9, 23 | -0.71 Decreased by -154.00% | -0.97 Increased by +26.68% |
| Aug 14, 23 | -3.78 Decreased by -845.00% | -3.30 Decreased by -14.55% |
| May 15, 23 | -0.23 Increased by +58.93% | -0.16 Decreased by -43.75% |
| Mar 16, 23 | -0.21 Increased by +61.11% | -0.28 Increased by +25.00% |
| Nov 14, 22 | -0.28 Increased by +55.56% | -0.33 Increased by +15.15% |
| Aug 11, 22 | -0.40 Increased by +24.53% | -0.43 Increased by +6.98% |
| May 12, 22 | -0.56 Decreased by -1.82% | -0.58 Increased by +3.45% |
| Mar 24, 22 | -0.54 Increased by +12.90% | -0.61 Increased by +11.48% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 0.00 Decreased by N/A% | -12.36 M Increased by +59.55% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -21.10 M Increased by +30.95% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -25.34 M Increased by +15.14% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -23.54 M Increased by +17.84% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -30.56 M Increased by +9.39% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 22 | 0.00 Decreased by N/A% | -30.56 M Increased by +3.28% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 22 | 0.00 Decreased by N/A% | -29.86 M Decreased by -5.91% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 21 | 0.00 Decreased by N/A% | -28.65 M Increased by +1.37% | Decreased by N/A% Decreased by N/A% |